Proscia to Collaborate with Columbia University on Biomarker Discovery for Neurodegenerative Diseases

Philadelphia - October 27, 2026 - Proscia has entered into a collaborative agreement with Columbia University to identify biomarkers for neurodegenerative diseases, such as Alzheimer’s and other dementias. The collaboration pairs Columbia’s...

A Mayo Clinic study published in the Journal of Neuro-Oncology suggests that analyzing DNA in cerebrospinal fluid could provide another source of information when MRI cannot provide a clear brain tumor diagnosis or obtaining tissue through...

Lunit and Summit Therapeutics: Research Will Use Lunit’s AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment Biology  Seoul, South Korea and Miami, Florida,...

AI models in GI/liver pathology using the Aiforia Platform Quantitative and predictive AI models in gastrointestinal and liver pathology: the Mayo Clinic experience 4 November 2026 - 12:00 PM (noon) EST REGISTER NOW Over the...

SimBioSys: Novel software transforms routinely collected MRI, pathology and clinical data into personalized five- and ten-year recurrence risk insight for women with early-stage breast cancer CHICAGO, IL – October 15, 2026 – SimBioSys®,...

Indica Labs: Learn About AI Model Interoperability with HALO AI Open AI Workflows in Digital Pathology: Model Interoperability with HALO® Date: 4 November 2026 Time: 8:00 – 9:00 PST | 11:00 – 12:00 EST | 16:00 – 17:00...